KSR1 Is Overexpressed in Endometrial Carcinoma and Regulates Proliferation and TRAIL-Induced Apoptosis by Modulating FLIP Levels
- 30 April 2011
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 178 (4), 1529-1543
- https://doi.org/10.1016/j.ajpath.2010.12.041
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanismsEuropean Journal Of Cancer, 2010
- KSR1 Is Required for Cell Cycle Reinitiation Following DNA DamagePublished by Elsevier BV ,2009
- CK2β Is Expressed in Endometrial Carcinoma and Has a Role in Apoptosis Resistance and Cell ProliferationThe American Journal of Pathology, 2009
- CK2 Is a Component of the KSR1 Scaffold Complex that Contributes to Raf Kinase ActivationCurrent Biology, 2007
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- mTOR-Independent Translational Control of the Extrinsic Cell Death Pathway by RalAMolecular and Cellular Biology, 2006
- The clinical trail of TRAILEuropean Journal Of Cancer, 2006
- TRAIL receptor–mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethalityJCI Insight, 2006
- Increased expression of FLIP, an inhibitor of Fas‐mediated apoptosis, in stomach cancerAPMIS, 2003
- Safety and antitumor activity of recombinant soluble Apo2 ligandJCI Insight, 1999